Skip to Content

WPI 2282 (Zolpidem tartrate extended-release 12.5 mg)

Pill imprint WPI 2282 has been identified as Zolpidem tartrate extended-release 12.5 mg.

Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 12.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Zolpidem tartrate extended-release
Imprint:
WPI 2282
Strength:
12.5 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-2282
Inactive Ingredients:
lactose anhydrous
silicon dioxide
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer
hydroxypropyl cellulose (type h)
hypromelloses
ferrosoferric oxide
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
polyethylene glycol
propylene glycol
sodium bicarbonate
sodium lauryl sulfate
magnesium silicate
titanium dioxide
triethyl citrate
polysorbate 80

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide